Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
As the cancer drug funding landscape continues to evolve, the need for RWE to support evidence-based policy reform, pricing and reallocation of funding from low to high value settings is crucial. We have developed a framework that is adaptable and responsive to the changing landscape. The tools, templates and processes within the framework can be applied by various stakeholder groups in whole or in part to support cancer drug funding decision-making in Canada and can be adapted for use in other jurisdictions.
Authors
- Tarry Ahuja
- Craig C. Earle (ORCID: https://orcid.org/0000-0002-0420-1999)
- Jeffrey S. Hoch (ORCID: https://orcid.org/0000-0002-4880-4281)
- Kelvin Chan (ORCID: https://orcid.org/0000-0002-2501-3057)
- Marc Geirnaert (ORCID: https://orcid.org/0000-0003-2264-7801)
- William K. Evans (ORCID: https://orcid.org/0000-0003-2069-1593)
- Yvonne Bombard (ORCID: https://orcid.org/0000-0002-9516-4539)
- Rebecca E. Mercer (ORCID: https://orcid.org/0000-0002-9264-7797)
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Winson Y. Cheung (ORCID: https://orcid.org/0000-0002-3679-4290)
- Maureen Trudeau (ORCID: https://orcid.org/0000-0002-0938-4499)
- Wanrudee Isaranuwatchai (ORCID: https://orcid.org/0000-0002-8368-6065)
- Pam Takhar
- Scott Gavura (ORCID: https://orcid.org/0000-0002-8635-6889)
- Stuart Peacock (ORCID: https://orcid.org/0000-0002-8243-8721)
- Petros Pechlivanoglou (ORCID: https://orcid.org/0000-0001-5090-7936)
- Caroline Muñoz
- Jaclyn Beca (ORCID: https://orcid.org/0000-0001-8858-9566)
- Carole Chambers (ORCID: https://orcid.org/0000-0003-0180-840X)
- Claire de Oliveira (ORCID: https://orcid.org/0000-0003-3961-6008)
- Erica Craig
- Avram Denburg (ORCID: https://orcid.org/0000-0003-0039-0742)
- Wei Fang Dai (ORCID: https://orcid.org/0000-0002-1416-1070)
- Riaz Alvi
Institutions
- Alberta Health Services (CA)
- Canadian Agency for Drugs and Technologies in Health (CA)
- BC Cancer Agency (CA)
- Sunnybrook Health Science Centre (CA)
- Centre for Addiction and Mental Health (CA)
- University of Calgary (CA)
- Public Health Agency of Canada (CA)
- University of Toronto (CA)
- Cancer Care Ontario (CA)
- Health Intervention and Technology Assessment Program (TH)
- Hospital for Sick Children (CA)
- Women's College Hospital (CA)
- Ontario Genomics (CA)
- Health Sciences Centre (CA)
- CancerCare Manitoba (CA)
- Saskatchewan Cancer Agency (CA)
- Public Health Ontario (CA)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- LEK Consulting (United States) (US)
- SickKids Foundation (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Canadian Centre for Applied Research in Cancer Control (CA)
- University of California, Davis (US)
- McMaster University (CA)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-096286
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.39
Funders
- Canadian Institutes of Health Research